BOROSCI
Borosil Scientific Ltd
- P/E
- 21.93
Key Fundamentals
MicrocapIndustrial ProductsCapital GoodsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 12.10%
- Debt to Equity
- 0.02
- EPS (TTM)
- ₹4.85
- Book Value
- ₹50.77
- Market Cap
- —
- P/E (TTM)
- 21.93
- P/B
- 2.09
- ROE
- 9.51%
- Dividend Yield
- 0.00%
- EBITDA
- —
- 52W High
- ₹180.80
- 52W Low
- ₹96.64
- Day Range
- ₹104.90 – ₹107.39
- Volume
- 69,409
Peer Comparison
Industrials › Industrial Products › Glass - Industrial
| ₹389.80 | 14.26 | ₹5,304 Cr | 2.95 | 0.00% | 27.70% | 26.60% | ₹1,608 Cr | ₹381 Cr | |
| BOROSCI (this company) | ₹106.34 | 21.93 | ₹944 Cr | 2.09 | 0.00% | 9.51% | 12.10% | ₹478 Cr | ₹43 Cr |
| ₹831.95 | 29.15 | ₹940 Cr | 5.97 | 0.00% | 31.10% | 18.60% | ₹437 Cr | ₹32 Cr | |
| ₹152.00 | — | ₹294 Cr | 2.17 | 0.00% | 20.60% | 23.00% | — | — | |
| ₹24.30 | 1.98 | ₹18 Cr | 0.88 | 0.00% | 7.64% | 10.10% | ₹48 Cr | ₹3 Cr | |
| ₹20.00 | 111.11 | ₹7 Cr | 9.52 | 0.00% | 8.63% | 11.20% | ₹4 Cr | ₹0 Cr | |
| Median 6 companies | ₹129.17 | 21.93 | ₹617 Cr | 2.56 | 0.00% | 15.06% | 15.35% | ₹437 Cr | ₹32 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 95/100
Category scores
- Quality
- 62
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 56
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 39
- Weak
- Sales & profit trajectory 9% weight
- Financial Health
- 83
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 23
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 44
- Weak
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Company's working capital requirements have reduced from 112 days to 84.0 days
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 7.61% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 5 | 4 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Neutral
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 44.03
- Neutral
- MACD (12,26,9)
- −3.27
- Bullish
- SMA (50)
- 115.94
- Bearish
- SMA (200)
- 125.47
- Bearish
As of
Growth Rate
From the financial statements below. 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 1Y | +6.45% |
|---|---|
| TTM | +11.22% |
Net profit
| 1Y | +29.63% |
|---|---|
| TTM | +146.66% |
Operating cash flow
| 1Y | −64.17% |
|---|---|
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 1Y | +1.43 pp |
|---|---|
| TTM | +2.77 pp |
Revenue by year
| Mar 2024 | ₹392 Cr |
|---|---|
| Mar 2025 | ₹434 Cr |
| Mar 2026 | ₹462 Cr |
Net profit by year
| Mar 2024 | ₹23.00 Cr |
|---|---|
| Mar 2025 | ₹27.00 Cr |
| Mar 2026 | ₹35.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 87.54 | 91.97 | 99.68 | 116 | 104 | 103 | 101 | 129 | 95.98 | 107 | 121 | 143 | 107 | 115 |
| Expenses | 81.82 | 82.5 | 87.53 | 97.44 | 94.37 | 87.16 | 91.44 | 113 | 91.12 | 98.87 | 104 | 111 | 98.3 | 104 |
| Operating Profit | 5.72 | 9.47 | 12.15 | 18.27 | 9.83 | 15.82 | 10.01 | 16.57 | 4.86 | 8.03 | 17.19 | 32.11 | 8.45 | 10.7 |
| OPM % | 6.53% | 10.3% | 12.19% | 15.79% | 9.43% | 15.36% | 9.87% | 12.8% | 5.06% | 7.51% | 14.17% | 22.43% | 7.92% | 9.31% |
| Other Income | 1.11 | 1.44 | 1.06 | 1.48 | 2.16 | 1.58 | 1.86 | 2.59 | −3.69 | 2.15 | 0.5 | 2.06 | 2.67 | 2.41 |
| Interest | 0.76 | 0.73 | 0.54 | 0.67 | 0.4 | 0.36 | 0.35 | 0.44 | 0.38 | 0.23 | 0.26 | 0.26 | 0.25 | 0.22 |
| Depreciation | 3.65 | 3.85 | 4.5 | 4.45 | 4.57 | 4.63 | 4.58 | 4.7 | 4.88 | 4.81 | 4.79 | 4.76 | 4.89 | 5.22 |
| PBT | 2.42 | 6.33 | 8.17 | 14.63 | 7.02 | 12.41 | 6.94 | 14.02 | −4.09 | 5.13 | 12.64 | 29.15 | 5.98 | 7.67 |
| Tax % | −35.54% | 20.22% | 30.48% | 35.27% | 28.49% | 29.09% | 38.33% | 38.52% | 3.18% | 44.36% | 31.25% | 6.52% | 27.09% | 30.77% |
| Net Profit | 3.29 | 5.05 | 5.69 | 9.46 | 5.02 | 8.8 | 4.28 | 8.62 | −4.21 | 2.85 | 8.7 | 27.25 | 4.35 | 5.31 |
| EPS (₹) | — | — | 0.65 | 1.05 | 0.57 | 0.99 | 0.48 | 0.97 | −0.47 | 0.32 | 0.98 | 3.06 | 0.49 | — |
Sep 2026: from the results filed on 28 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|
| Sales | 392 | 434 | 462 | 478 |
| Expenses | 345 | 381 | 400 | 412 |
| Operating Profit | 47 | 53 | 63 | 66 |
| OPM % | 12% | 12% | 14% | 14% |
| Other Income | 4 | 8 | 0 | 7 |
| Interest | 3 | 2 | 1 | 1 |
| Depreciation | 16 | 18 | 19 | 19 |
| PBT | 32 | 40 | 43 | 53 |
| Tax % | 26% | 34% | 19% | — |
| Net Profit | 23 | 27 | 35 | 43 |
| EPS (₹) | 2.65 | 3.01 | 3.89 | 4.85 |
| Div. Payout % | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity Capital | 9 | 9 | 9 |
| Reserves | 367 | 395 | 432 |
| Borrowings | 18 | 14 | 9 |
| Other Liabilities | 95 | 86 | 90 |
| Total Liabilities | 488 | 504 | 540 |
| Fixed Assets | 192 | 187 | 189 |
| CWIP | 1 | 1 | 9 |
| Investments | 0 | 105 | 122 |
| Other Assets | 295 | 210 | 220 |
| Total Assets | 488 | 504 | 540 |
Cash Flow
₹ Cr| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Operating | 30 | 120 | 43 |
| Investing | −2 | −115 | −37 |
| Financing | −16 | −3 | −6 |
| Net Cash Flow | 12 | 1 | 0 |
| Free Cash Flow | 17 | 106 | 16 |
| CFO/OP | 97 | 249 | 92 |
Ratios
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Debtor Days | 57 | 59 | 60 |
| Inventory Days | 244 | 218 | 226 |
| Days Payable | 102 | 79 | 93 |
| Cash Conversion Cycle | 200 | 199 | 193 |
| Working Capital Days | 165 | 86 | 84 |
| ROCE % | — | 10% | 12% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view BOROSCI insights
62 extracted metrics across FY23–FY27.
Documents
- 9 Dec 2025
- 11 Dec 2024
- General announcements 28 Oct 2026
- General announcements 6 Oct 2026
Frequently Asked Questions about BOROSCI
What does Borosil Scientific Ltd do?
Where is Borosil Scientific Ltd (BOROSCI) listed?
Which sector does Borosil Scientific Ltd belong to?
What is the PE ratio of Borosil Scientific Ltd?
What is the 52-week high and low of Borosil Scientific Ltd?
What is the Return on Equity (ROE) of Borosil Scientific Ltd?
Company Information
Since 1962, Borosil is into finest quality scientific and laboratory glassware, which is used in Quality Control in pharmaceutical industries, Food and Soil testing, Microbiology, and Biotechnology.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BOROSCI.md for Borosil Scientific Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.